Most Down Articles

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

Most Downloaded in Recent Year

Please wait a minute...


For Selected: Download Citations EndNote Ris BibTeX Toggle Thumbnails

Select

China Journal of Oral and Maxillofacial Surgery    2007, 5 (2): 83-90.   Abstract （1934）      PDF （1354KB）（3940）       Knowledge map    Related Articles | Metrics

Select

Expert consensus on diagnosis and clinical management of medication-related osteonecrosis of the jaw HE Yue, CHEN Heng, AN Jin-gang, GUO Yu-xing, PAN Jian, TIAN Lei, LIU Bing, HOU Jin-song, LI Jin-song, JIANG Can-hua, LI Meng-yu, TIAN Zhen, XU Jie, ZHU Ling, SUN Chang-fu, ZHI Ke-qian, QU Qing, ZONG Chun-lin, SUN Jing-jing, ZHANG Zhi-yuan China Journal of Oral and Maxillofacial Surgery    2023, 21 (4): 313-325.   DOI: 10.19438/j.cjoms.2023.04.001 Abstract （534）      PDF （2051KB）（734）       Knowledge map    Medication-related osteonecrosis of the jaw(MRONJ) is a complication caused by the application of anti-resorptive medications, angiogenesis inhibitors, hormones and other medications for the treatment of some systemic diseases. The clinical symptoms include swelling, pain, masticatory disorders, persistent fistula, bone exposure and even pathological fracture, which seriously affect the patients' quality of life. Domestically, there is a lack of consensus or guidelines on classification, staging and treatment of MRONJ, and different institutions make diagnosis and treatment plans empirically. In order to unify and standardize the diagnosis and treatment of MRONJ and improve the prognosis, an expert panel of MRONJ research from 12 famous domestic medical colleges and affiliated hospitals convened a meeting to discuss the diagnosis and treatment opinions of MRONJ. Meanwhile, consensus recommendations were also revised with a comprehensive literature review of the previous treatment experiences and research findings. Finally, this expert consensus was finished for clinical references. Reference | Related Articles | Metrics

Select

Clinical application of Tent-Peg technique in the reparation and regeneration of alveolar bone-standard operational practice ZOU Duo-hong, LIU Chang-kui, XUE Yang, HU Kai-jin, YANG Chi, ZHNAG Zhi-yuan China Journal of Oral and Maxillofacial Surgery    2021, 19 (1): 1-5.   DOI: 10.19438/j.cjoms.2021.01.001 Abstract （2023）      PDF （3998KB）（1347）       Knowledge map    ] Alveolar bone is the foundation of dentology. The reparation and regeneration of alveolar bone defects have strong relationship with sub-disciplines including implant dentistry, orthodontics, periodontology and prosthodontics. Therefore, the effective methods of repairing and reconstructing alveolar bone have important clinical significance and great social benefits. With the development of guide bone regeneration (GBR) technique and advent of alveolar bone regeneration based on stability centered concept, an entirely new bone augmentation approach based on Tent-Peg technique developed rapidly and was validated in clinical practices. The technique is characterized by low technique sensitivity, simple operation procedure, short operation time and low costs. Furthermore, alveolar bone regeneration based on this technique can be achieved with just artificial biomaterials instead of autogenous bone grafts. In conjunction with its advantages, Tent-Peg technique is increasingly favored and valued by patients and clinicians. However, clinicians still face many difficulties achieving effectively clinical application of this technique, including standard operation practice, right position of the Tent-Peg, proper orientation of the pegs and right order of placing GBR membrane and Tent-Peg. Our team established standard operation practice of Tent-Peg technique for alveolar bone regeneration based on clinical practice. We hope that this article will provide a reference and basis for clinicians when applying this technique for alveolar bone regeneration, popularize the clinical application of this technique and finally offer practical help to patients suffering from alveolar bone defects. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2017, 15 (2): 185-188.   DOI: 10.19438/j.cjoms.2017.02.018 Abstract （355）      PDF （2529KB）（913）       Knowledge map    Reference | Related Articles | Metrics

Select

Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas(version 2022) ZHENG Jia-wei, WANG Xu-kai, QIN Zhong-ping, FAN Xin-dong, LI Kai, YANG Yao-wu, HUO Ran, LIU Shao-hua, ZHAO Ji-hong, WANG Xiao-yong, ZHOU De-kai, LIU Xue-jian China Journal of Oral and Maxillofacial Surgery    2022, 20 (4): 313-319.   DOI: 10.19438/j.cjoms.2022.04.001 Abstract （795）      PDF （1061KB）（638）       Knowledge map    Since 2008, propranolol has become the first-line treatment for infantile hemangiomas. Many researches have been reported on its treatment mechanism both at home and abroad, and several expert consensus or clinical practice guidelines have been formulated and published. In recent years, with the continuous accumulation of clinical experience, increasing number of basic research works, and deepening understanding of the pathogenesis of hemangioma and the mechanism of action of propranolol, it is necessary to update the expert consensus to be more consistent with clinical practice, in order to guide medication and management, provide scientific norms for the clinical use of propranolol in the treatment of infantile hemangiomas. This updated version mainly simplified the process of clinical examination, medication, and monitoring, making it more convenient and operable. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2009, 7 (2): 168-175.   Abstract （505）      PDF （1607KB）（1702）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2006, 4 (6): 467-470.   Abstract （1876）      PDF （747KB）（1015）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2012, 10 (6): 516-521.   Abstract （502）      PDF （783KB）（1343）       Knowledge map    Related Articles | Metrics

Select

Familial gigantiform cementoma: analysis of a large Chinese pedigree WANG Hong-wei, YU Miao, QIN Xing-jun, WANG Li-zhen, XU Li-qun, ZHANG Chen-ping China Journal of Oral and Maxillofacial Surgery    2014, 12 (4): 360-364.   Abstract （456）   HTML （2）    PDF （1571KB）（1035）       Knowledge map    PURPOSE: Familial gigantiform cementoma (FGC) is a rare autosomal dominant benign odontogenic tumor. The purpose of this study is to describe the clinical characteristics of FGC in a Chinese family with multiple-affected members. METHODS: Detail screening was conducted on family members of a 13-year-old Chinese male with recent diagnosis of FGC. All family members of the patient were interviewed. Demographic, past medical and surgical histories were collected from family members with history of FGC diagnosis. Clinical information related to the lesions (symptom, age of onset, history of treatment, histological and radiological findings) was obtained. Literature review was also presented in this study. RESULTS: In this study, we found a four-generation Han Chinese family with thirteen affected members with diagnosis of FGC. Eight male patients and five female patients were appreciated in the study. All 13 patients experienced the onset of symptoms at 11-13 years old followed by a rapid and expansive growth phrase at the age of 14-16, and growth suppression phase around age 18 to 20 years old. Eight patients in our series had sustained multiple pathological long bone fractures (average 3-4 x/person) between the age of 13 and 16 years. CONCLUSIONS: The familial history of this case helps to demonstrate that the inheritance pattern of FGC was autosomal dominant. FGC usually presented with three distinctive growth phrases: ①Initial onset; ②Rapid expansion; ③Growth suppression phase. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2005, 3 (1): 3-9.   Abstract （1732）      PDF （611KB）（1821）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2007, 5 (4): 243-248.   Abstract （1460）      PDF （852KB）（1146）       Knowledge map    Related Articles | Metrics

Select

Guideline on pathological diagnosis of oral and oropharyngeal squamous cell carcinoma Society of Oral Pathology, Chinese Stomatological Association China Journal of Oral and Maxillofacial Surgery    2020, 18 (4): 289-296.   DOI: 10.3760/cma.j.issn.1002-0098.2020.03.001 Abstract （1032）      PDF （7417KB）（672）       Knowledge map    Oral and oropharyngeal squamous cell carcinomas are the most common malignant tumours of the oral and maxillofacial region. A standardized pathological diagnosis report for oral and oropharyngeal squamous cell carcinoma should provide not only the pathological diagnosis itself as much accurate as possible, but also the information related to assessment of prognosis and strategy of treatment for the patient. An expert group organized by Society of Oral Pathology, Chinese Stomatological Association has set a guideline for the tissue fixation, gross examination and format of the pathological diagnosis report of oral and oropharyngeal squamous cell carcinoma. The guideline covers the important changes in clinical and pathological aspects of oral and oropharyngeal squamous cell carcinomas in recent years, such as depth of invasion in T category, extranodal extension in N category and human papilloma virus-associated squamous cell carcinoma in oropharyngeal carcinomas. Hopefully the guideline will improve the quality of pathological reports of oral and oropharyngeal squamous cell carcinomas and provide reliable data on clinical therapy and prognosis evaluation of patients with oral and oropharyngeal squamous cell carcinomas in China. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2007, 5 (3): 188-194.   Abstract （809）      PDF （1128KB）（830）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2010, 8 (6): 521-524.   Abstract （367）      PDF （726KB）（579）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2011, 9 (4): 316-322.   Abstract （391）      PDF （901KB）（1543）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2009, 7 (5): 465-467.   Abstract （231）      PDF （583KB）（545）       Knowledge map    Related Articles | Metrics

Select

Application of surgical navigation in treatment of Eagle's syndrome DOU Geng, ZHANG Yu, TIAN Lei China Journal of Oral and Maxillofacial Surgery    2016, 14 (3): 244-248.   Abstract （431）   HTML （1）    PDF （1814KB）（939）       Knowledge map    PURPOSE: To evaluate the feasibility, accuracy and clinical effect of intra-operative navigation for resection of elongated styloid process (ESP) in Eagle's syndrome. METHODS: Twelve patients with Eagle's syndrome with clinically and radiologically established diagnosis of ESP were enrolled. Preoperatively, the patients' Dicom data of skulls were input into the navigation system workstation to mark the ESP and make surgical plan in advance. During surgery, the intraoperative navigation was performed on all patients to excise the ESP accurately through both intraoral (without tonsillectomy) and extraoral approach following the operative plan. Postoperatively, the amount of bleeding, duration of operation and hospitalization and the length of resected SP were measured and compared with those through traditional styloidectomy without assistance of surgical navigation. A questionnaire and a simple visual analogue scale (VAS) was also used to assess patient's satisfaction and the surgical effect 3 months after surgery using SPSS 19.0 software package. RESULTS: In total, 17 styloid processes from 12 patients were precisely resected by intraoral parapharyngeal approach and small cervical approach with aid of surgical navigation. No severe surgical complications occurred in all patients. The length of resected styloid processes was (21.93±14.26) mm. The average amount of bleeding and duration of operation were (22.50±8.54) mL and (40.35±11.81) min, respectively, which are lower than traditional operation without aid of surgical navigation. VAS analysis showed that discomfort in all patients were relieved, while 10 patients' symptoms were improved obviously and 2 patients had some improvement. CONCLUSIONS: The high accuracy of surgery, lesser amount of bleeding, shorter duration of surgery and hospitalization, minimal complications and improved subjective symptoms certify that surgical navigation is a more effective and minimally invasive surgical procedure to treat Eagle's syndrome. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2010, 8 (2): 123-129.   Abstract （771）      PDF （1218KB）（591）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2010, 8 (2): 98-106.   Abstract （929）      PDF （1489KB）（7096）       Knowledge map    Related Articles | Metrics

Select

Overview of current pharmacotherapy for infantile hemangiomas ZHENG Jia-wei, MA Kun-ning, ZHANG Ling China Journal of Oral and Maxillofacial Surgery    2014, 12 (1): 1-6.   Abstract （504）   HTML （3）    PDF （893KB）（694）       Knowledge map    Infantile hemangiomas (IH) are the most common tumors of infancy and childhood. 60% of them are localized in the head and neck region. They may impinge on vital structures, ulcerate, bleed, cause high-output cardiac failure or significant disfigurement if left untreated. The traditional treatment methods include drug therapy, laser therapy and surgery, with drug therapy being the mainstay of treatment. The medications most commonly used to treat IH are corticosteroids, beta-adrenergic blocker, pingyangmycin, interferon alfa, imiquimod, and etc. For function- and life-threatening infantile hemangioma, some anti-cancer agents like vincristine may be used as an effective alternative option. This succinct review summarized current pharmacotherapeutic therpy of IH, especially the properties and effectiveness of various beta-adrenergic antagonists in the management of IH. Reference | Related Articles | Metrics